Oppenheimer Cuts Bioceres Crop Solutions (NASDAQ:BIOX) Price Target to $13.00

Bioceres Crop Solutions (NASDAQ:BIOX) had its target price lowered by Oppenheimer from $16.00 to $13.00 in a research note issued to investors on Monday morning, Benzinga reports. Oppenheimer currently has an outperform rating on the stock.

A number of other analysts have also recently weighed in on the stock. Roth Mkm decreased their price target on shares of Bioceres Crop Solutions from $15.00 to $13.00 and set a “buy” rating for the company in a research note on Wednesday, September 11th. Canaccord Genuity Group decreased their price target on shares of Bioceres Crop Solutions from $12.50 to $10.00 and set a “buy” rating for the company in a research note on Thursday, October 17th. Lake Street Capital reduced their target price on shares of Bioceres Crop Solutions from $25.00 to $13.00 and set a “buy” rating for the company in a research note on Wednesday, September 11th. Roth Capital upgraded shares of Bioceres Crop Solutions to a “strong-buy” rating in a research note on Tuesday, July 2nd. Finally, Canaccord Genuity Group upgraded shares of Bioceres Crop Solutions to a “strong-buy” rating in a research note on Friday, July 19th. Four investment analysts have rated the stock with a buy rating and two have issued a strong buy rating to the company’s stock. According to MarketBeat, Bioceres Crop Solutions currently has a consensus rating of “Buy” and an average price target of $12.25.

Bioceres Crop Solutions Stock Down 1.7 %

Shares of NASDAQ:BIOX opened at $7.42 on Monday. The stock has a market cap of $465.95 million, a P/E ratio of 742.00 and a beta of 0.47. The firm has a fifty day moving average price of $8.87 and a 200 day moving average price of $10.47. The company has a debt-to-equity ratio of 0.35, a current ratio of 1.28 and a quick ratio of 0.91. Bioceres Crop Solutions has a 1-year low of $7.15 and a 1-year high of $14.05.

Bioceres Crop Solutions (NASDAQ:BIOX) last issued its quarterly earnings results on Monday, September 9th. The company reported ($0.03) earnings per share for the quarter, missing analysts’ consensus estimates of $0.20 by ($0.23). The business had revenue of $124.30 million for the quarter, compared to analyst estimates of $126.75 million. Bioceres Crop Solutions had a return on equity of 0.93% and a net margin of 0.68%. During the same quarter in the prior year, the company earned ($0.06) EPS. Sell-side analysts predict that Bioceres Crop Solutions will post 0.39 EPS for the current year.

Institutional Trading of Bioceres Crop Solutions

Several hedge funds have recently made changes to their positions in BIOX. Oppenheimer & Co. Inc. acquired a new stake in shares of Bioceres Crop Solutions in the first quarter valued at about $139,000. Lazard Asset Management LLC acquired a new stake in shares of Bioceres Crop Solutions in the first quarter valued at about $212,000. Ping Capital Management Inc. acquired a new stake in shares of Bioceres Crop Solutions in the second quarter valued at about $448,000. Sumitomo Mitsui Trust Holdings Inc. acquired a new stake in shares of Bioceres Crop Solutions in the second quarter valued at about $472,000. Finally, Dimensional Fund Advisors LP lifted its stake in shares of Bioceres Crop Solutions by 9.5% in the second quarter. Dimensional Fund Advisors LP now owns 61,330 shares of the company’s stock valued at $688,000 after purchasing an additional 5,341 shares during the period. Institutional investors and hedge funds own 17.68% of the company’s stock.

Bioceres Crop Solutions Company Profile

Bioceres Crop Solutions Corp., together with its subsidiaries, provides crop productivity solutions. It operates through Seed and Integrated Products, Crop Protection, and Crop Nutrition segments. The Seed and Integrated Products segment provides seed traits, germplasms, and seed treatment packs for healthier, and higher yielding crops.